Selected data models

You must log in to select data models for download or further analysis.

2 Search results.
Relevance Rating New first Old first

WTZ-GIST-09-01 (Imatinib + LBH589) Informed Consent 2009-011417-24 DRKS00000657 - WTZ-GIST-09-01 (Imatinib + LBH589) Informed Consent 2009-011417-24

- 11/23/16 - 1 form, 1 itemgroup, 3 items, 1 language
Itemgroup: Informed Consent
Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors WTZ-GIST-09-01 (EudraCT number: 2009-011417-24; German Clinical Trials Register: DRKS00000657) was approved by the institutional ethics committees of the two participating centers and the German Federal Regulatory Drug Agency (BfArM; 4035954).

Ropinirole prolonged release (PR) as adjunctive treatment to L-Dopa in patients with advanced Parkinson's disease (NCT01494532) - Baseline - Consent; Central Laboratory; Diary; ECG

- 1/9/20 - 1 form, 11 itemgroups, 56 items, 1 language
Itemgroups: Administrative, Randomisation, Electronically Transferred Lab Data, Possible Liver Events, Diary - Target Day 1, Diary - Target Day 2, Diary Day 2, Target Day 3, Diary Day 3, 12 Lead Electrocardiogram , ECG Information
Study ID: 111569 Clinical Study ID: 111569 Study Title: A fixed dose, dose-response study for ropinirole prolonged release (PR) as adjunctive treatment to L-Dopa in patients with advanced Parkinson's disease Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01494532 Sponsor: GlaxoSmithKline Phase: Phase 4 Study Recruitment Status: Completed Generic Name: Ropinirole, placebo Study Indication: Parkinson's Disease

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial